bn:21811105n
Noun Named Entity
Categories: Gene therapy, Articles without KEGG source, Drugs with no legal status, Infobox drug articles with non-default infobox title, Chemical pages without DrugBank identifier
EN
Cambiogenplasmid  Neovasculgen
EN
Cambiogenplasmid, marketed as Neovasculgen, is a gene therapy drug for treatment of peripheral artery disease, including critical limb ischemia; it delivers the gene encoding for vascular endothelial growth factor. Wikipedia
Definitions
Relations
Sources
EN
Cambiogenplasmid, marketed as Neovasculgen, is a gene therapy drug for treatment of peripheral artery disease, including critical limb ischemia; it delivers the gene encoding for vascular endothelial growth factor. Wikipedia
Wikipedia
Wikidata
Wikipedia Redirections
Wikidata Alias